Decision Diagnostics Corp (DECN)

[loanranger]

You are posting to "None", but I understand this to be your question:
What might precipitate a move of DECN's trading to the Grey Sheets?
("DECN will soon be on the grey sheets and a few saying no they won't.")

The typical route to the grey sheets for an OTC Pink stock is via a 10 day trading suspension based on questions about adequacy and/or accuracy of company information, including news releases, share issuances, stock promotions, etc. The risk of a trading suspension based on the failure to file "current reports" ended with the Form 15 filing, which relieved the company of that obligation.
When the 10 day suspension ends so does the normal process of bid and ask quoting by market makers. In the absence of that activity there is no formal trading and the share price typically opens sharply down after the ten day suspension. You may as well call your friends and ask them if they would like to trade at that point. If you're really lucky your broker will have several customers holding the shares.


Are there questions about the adequacy and/or accuracy of DECN's public information? Can any material information provided in their press releases be shown to be false? Have there been unexplained share issuances or unusual trading activity?
Those are the kinds of thing the SEC would be concerned about IF they were to look at DECN. Because the 10 day suspension has such dire consequences the SEC doesn't use it injudiciously. Once you're on the grey sheets the party is over...the exceptions are EXTREMELY rare (I think there have been two). Trading trickles over time to a virtual stop. For OTC stocks the end comes when FINRA cancels the symbol.

Looking at the SEC litigation releases and trading suspension orders on the SEC website would resolve the "haven't seen any supportive evidence for either perspective" issue...I would suggest that you do that.
You didn't ask for and may not like an example of what could precipitate a suspension here, but I've always learned most by example. It is presented as a HYPOTHETICAL.
If the following statements were shown not to be true and the orders referenced therein had not actually been placed, then a suspension COULD result:
"Macre Diagnostics S.R.L. has become the company's distributor to multiple countries in South America. Macre, located in Santa Cruz, Bolivia has secured its regulatory approvals and has placed an initial opening order for 10,800 pieces of GenUltimate! with a 12 month cumulative order for 2,850,000 pieces of GenUltimate!"
However, the absence of a significant market reaction to the release makes it a lot less likely that it would get the SEC's attention in the first place. The SEC acts when it feels investors need protecting and volume is usually an attention getter for them.